Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
La guía 2016 sobre interacciones entre medicamentos psicotrópicos, Part 2
1
x
$
15.00
Síndrome de Interrupción del ISRS: Un nuevo problema antiguo
1
x
$
0.00
Paroxetine Treatment of Generalized Anxiety Disorder
1
x
$
30.00
Diferencias de género en el trastorno depresivo mayor y el trastorno bipolar
1
x
$
0.00
Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
1
x
$
30.00
Neuropsicofarmacología geriátrica: una guía sobre dosificación y monitoreo de sustancias psicotrópicas en la población geriátrica
1
x
$
0.00
Placebo Response in Depression: A Perspective for Clinical Practice
1
x
$
30.00
Psiquiatría y Salud Integral: afronta la psiquiatría geriátrica
1
x
$
0.00
Caso clínico: Disfunción auditiva funcional (Síndrome de King-Kopetksy) asociada a un trastorno depresivo mayor
1
x
$
0.00
View Cart
Checkout
Home
martin-brecher
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
$
30.00
Add to cart
Details
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
$
30.00
Add to cart
Details
Page load link
Go to Top
